2021
DOI: 10.3389/fgene.2021.662908
|View full text |Cite
|
Sign up to set email alerts
|

Deciphering Myostatin’s Regulatory, Metabolic, and Developmental Influence in Skeletal Diseases

Abstract: Current research findings in humans and other mammalian and non-mammalian species support the potent regulatory role of myostatin in the morphology and function of muscle as well as cellular differentiation and metabolism, with real-life implications in agricultural meat production and human disease. Myostatin null mice (mstn−/−) exhibit skeletal muscle fiber hyperplasia and hypertrophy whereas myostatin deficiency in larger mammals like sheep and pigs engender muscle fiber hyperplasia. Myostatin’s impact exte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 116 publications
(216 reference statements)
0
9
0
Order By: Relevance
“…Hence, our data suggest that, in the absence of comorbidities, myostatin knockout (GDF8 -/- ), although enhanced muscle mass, moderately influences bone phenotype in adult mice. However, other studies in mouse models of osteoporosis, osteoarthritis, osteogenesis imperfecta, muscular dystrophy, and diabetes show that pharmacological inhibition of myostatin improves muscle and bone properties to a greater extend 60 . Myostatin inhibition also ameliorates obesity-induced bone loss and trabecular architecture deterioration in rats 61 .…”
Section: Discussionmentioning
confidence: 96%
“…Hence, our data suggest that, in the absence of comorbidities, myostatin knockout (GDF8 -/- ), although enhanced muscle mass, moderately influences bone phenotype in adult mice. However, other studies in mouse models of osteoporosis, osteoarthritis, osteogenesis imperfecta, muscular dystrophy, and diabetes show that pharmacological inhibition of myostatin improves muscle and bone properties to a greater extend 60 . Myostatin inhibition also ameliorates obesity-induced bone loss and trabecular architecture deterioration in rats 61 .…”
Section: Discussionmentioning
confidence: 96%
“…[332][333][334] Besides sarcopenia and musculoskeletal diseases, alterations in myostatin are also found in the pathophysiology of myocardial infarctions, inflammation, IR, diabetes, cachexia and cancer. 335 Serum myostatin levels were significantly higher in HCC patients as compared to healthy controls and showed a positive correlation with sarcopenia. 282 Thus role of myostatin in NAFLD and NASH related HCC warrants further investigation.…”
Section: Myostatinmentioning
confidence: 89%
“…In aged patients high myostatin and IR coexists with NAFLD and sarcopenia thereby connecting the three vital metabolic organs namely liver, adipose tissue, and skeletal muscle 332–334 . Besides sarcopenia and musculoskeletal diseases, alterations in myostatin are also found in the pathophysiology of myocardial infarctions, inflammation, IR, diabetes, cachexia and cancer 335 . Serum myostatin levels were significantly higher in HCC patients as compared to healthy controls and showed a positive correlation with sarcopenia 282 .…”
Section: Myokinesmentioning
confidence: 98%
“…Myostatin-null mice (MSTN−/−) exhibit skeletal muscle fiber hyperplasia and hypertrophy, whereas myostatin deficiency in larger mammals, such as sheep and pigs, can result in muscle fiber hyperplasia. Myostatin's impact extends beyond muscles, with alterations in myostatin present in the pathophysiology of myocardial infarctions, inflammation, insulin resistance, diabetes, aging, cancer cachexia, and musculoskeletal disease [31].…”
Section: Discussionmentioning
confidence: 99%